Sabra Health Care REIT (SBRA) EV to EBITDA (2016 - 2026)

Sabra Health Care REIT has reported EV to EBITDA for 11 years, with the latest figure at 1581.57 in Q2 2026.

• On a quarterly basis, EV to EBITDA rose 3290.63% year-over-year to 1581.57 in Q2 2026; TTM through Jun 2026 was 26.95, a 83.4% increase from a year earlier, with the FY2025 full-year figure at 17.67, up 6.05% from the prior year.
• EV to EBITDA was 1581.57 for Q2 2026 at Sabra Health Care REIT, up from 69.8 in the prior quarter.
• The five-year high for EV to EBITDA was 1581.57 in Q2 2026, with the low at 166.89 in Q3 2022.
• Average EV to EBITDA over 5 years is 150.3, with a median of 69.91 recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: EV to EBITDA slumped 338.02% in 2022, then soared 3290.63% in 2026.
• Over 5 years, EV to EBITDA stood at 89.9 in 2022, then decreased by 21.85% to 70.26 in 2023, then decreased by 23.33% to 53.87 in 2024, then jumped by 58.74% to 85.51 in 2025, then soared by 1749.62% to 1581.57 in 2026.
• The last three EV to EBITDA figures came in at 1581.57 (Q2 2026), 69.8 (Q1 2026), and 85.51 (Q4 2025), per Business Quant data.